Jennifer K Litton

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. pmc Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
    Oncologist 18:369-76. 2013
  2. doi request reprint Breast cancer and fertility
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Curr Treat Options Oncol 13:137-45. 2012
  3. ncbi request reprint Multifocal breast cancer in women < or =35 years old
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 110:1445-50. 2007
  4. doi request reprint Earlier age of onset of BRCA mutation-related cancers in subsequent generations
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 118:321-5. 2012
  5. doi request reprint Aromatase inhibitors and breast cancer prevention
    Jennifer Keating Litton
    The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, 1515 Holcombe Boulevard, Unit 1354, Houston, TX 77030, USA
    Expert Opin Pharmacother 13:325-31. 2012
  6. pmc Breast cancer and pregnancy: current concepts in diagnosis and treatment
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Oncologist 15:1238-47. 2010
  7. pmc Breast cancer diagnosis during pregnancy
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
    Womens Health (Lond Engl) 5:243-9. 2009
  8. pmc Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 115:1598-604. 2009
  9. doi request reprint Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype
    Rachel L Theriault
    Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Clin Breast Cancer 11:325-31. 2011
  10. pmc Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
    Abigail S Caudle
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Hermann Pressler Drive, Unit 1484, Houston, TX 77030, USA
    Breast Cancer Res 14:R83. 2012

Detail Information

Publications27

  1. pmc Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Unit 1354, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
    Oncologist 18:369-76. 2013
    ..The purpose of this analysis was to compare disease-free survival (DFS), progression-free survival (PFS), and overall survival (OS) between pregnant and nonpregnant patients with breast cancer...
  2. doi request reprint Breast cancer and fertility
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Curr Treat Options Oncol 13:137-45. 2012
    ..Further safety and outcomes studies are warranted for children...
  3. ncbi request reprint Multifocal breast cancer in women < or =35 years old
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 110:1445-50. 2007
    ..The relation that multifocality at diagnosis had to survival in women < 35 years of age was evaluated...
  4. doi request reprint Earlier age of onset of BRCA mutation-related cancers in subsequent generations
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 118:321-5. 2012
    ..In this study, the authors assessed age at diagnosis in 2 generations of families with known mutations to investigate for earlier onset in subsequent generations...
  5. doi request reprint Aromatase inhibitors and breast cancer prevention
    Jennifer Keating Litton
    The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, 1515 Holcombe Boulevard, Unit 1354, Houston, TX 77030, USA
    Expert Opin Pharmacother 13:325-31. 2012
    ..The aromatase inhibitors are being actively evaluated as prevention agents for women with a history of ductal carcinoma in situ as well as for women who are considered to be at high risk for developing primary invasive breast cancer...
  6. pmc Breast cancer and pregnancy: current concepts in diagnosis and treatment
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Oncologist 15:1238-47. 2010
    ..This review details the available data regarding the diagnosis and management of the pregnant breast cancer patient...
  7. pmc Breast cancer diagnosis during pregnancy
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
    Womens Health (Lond Engl) 5:243-9. 2009
    ..In this article, the use of diagnostic imaging, procedures, surgery and chemotherapy are reviewed as well as prognosis and future pregnancies after the treatment for breast cancer...
  8. pmc Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 115:1598-604. 2009
    ..Women at a high risk for breast cancer are offered choices for screening or prophylactic surgeries. The aim of this study was to evaluate opinions regarding screening and surgical strategies in high-risk women...
  9. doi request reprint Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype
    Rachel L Theriault
    Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Clin Breast Cancer 11:325-31. 2011
    ..This article evaluates the risk of recurrence for patients who have small node-negative breast cancer by age and tumor subtype...
  10. pmc Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
    Abigail S Caudle
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Hermann Pressler Drive, Unit 1484, Houston, TX 77030, USA
    Breast Cancer Res 14:R83. 2012
    ....
  11. pmc Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass
    Henry M Kuerer
    Department of Surgical Oncology, DCIS Discovery Enterprise, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77230 1402, USA
    Breast Cancer Res Treat 133:1131-41. 2012
    ..Furthermore, there was no significant difference in risk of recurrence between diabetic patients receiving metformin or not. In conclusion, higher BMI is not associated with adverse biologic features or prognosis in patients with DCIS...
  12. doi request reprint Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy
    Ranjna Sharma
    Department of Surgical Oncology, Plastic Surgery, Radiation Oncology, and Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Plast Reconstr Surg 127:1763-72. 2011
    ....
  13. doi request reprint Triple-negative breast cancer is not a contraindication for breast conservation
    Farrell C Adkins
    Department of Surgical Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 18:3164-73. 2011
    ..Triple-negative breast cancer (TNBC) is an aggressive subtype shown to have a high risk of locoregional recurrence (LRR). The purpose of this study was to determine the impact of operation type on LRR in TNBC patients...
  14. pmc Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach
    Beth M Beadle
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 73:734-44. 2009
    ..The goal of this study is to determine the impact of locoregional treatment strategy, breast-conserving therapy (BCT), mastectomy alone (M), or mastectomy with adjuvant radiation (MXRT), on LRR for patients 35 years or younger...
  15. pmc Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
    Soley Bayraktar
    Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 118:1202-11. 2012
    ..In the current study, the authors explored the association between metformin use and survival outcomes in patients with triple receptor-negative breast cancer (TNBC) who were receiving adjuvant chemotherapy...
  16. pmc The impact of pregnancy on breast cancer outcomes in women<or=35 years
    Beth M Beadle
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 115:1174-84. 2009
    ..The purpose of the current study was to compare locoregional recurrence (LRR), distant metastases (DM), and overall survival (OS) in young patients with PABC and non-PABC...
  17. doi request reprint Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy
    David C Weksberg
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 20:3430-7. 2013
    ..We characterize the clinical course and predictive features of salvage treatment for LRR after breast conserving therapy (BCT) analyzed by initial treatment...
  18. pmc High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller
    Ana M Gonzalez-Angulo
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Clin Oncol 27:5700-6. 2009
    ..To evaluate the risk of recurrence in women diagnosed with T1a and T1b, node-negative, human epidermal growth factor receptor 2 (HER2) -positive breast cancer...
  19. doi request reprint Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers
    Catherine M Kelly
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Cancer 116:5161-7. 2010
    ..The authors hypothesized that the test is ordered when clinicopathological variables yield equivocal risk estimates. The current study also showed how often the test clarifies clinically ambiguous risk status...
  20. doi request reprint Clinical application of breast cancer risk assessment models
    Kaylene Ready
    The Univeristy of Texas MD Anderson Cancer Center, Houston, 77030, USA
    Future Oncol 6:355-65. 2010
    ..Their clinical applications are also outlined and clinical situations appropriate for each model are reviewed...
  21. doi request reprint Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer
    Huong T Le-Petross
    Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Cancer 117:3900-7. 2011
    ..In this study, the authors investigated the efficacy of alternating screening mammography and breast MRI every 6 months in women who had a genetically high risk of developing breast cancer...
  22. pmc Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer
    Ana M Gonzalez-Angulo
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Clin Cancer Res 17:1082-9. 2011
    ..Survival was estimated by Kaplan-Meier method and compared with log-rank. Cox proportional hazards models were fit to determine the independent association of mutation status with outcome...
  23. doi request reprint Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 26:4072-7. 2008
    ..To understand the mechanism through which obesity in breast cancer patients is associated with poorer outcome, we evaluated body mass index (BMI) and response to neoadjuvant chemotherapy (NC) in women with operable breast cancer...
  24. doi request reprint Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations
    Soley Bayraktar
    Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Breast Cancer Res Treat 130:145-53. 2011
    ..Further studies need to evaluate whether different therapies will change the outcome in these subgroups of TNBC...
  25. pmc Early onset HER2-positive breast cancer is associated with germline TP53 mutations
    Amal Melhem-Bertrandt
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 118:908-13. 2012
    ..Germline TP53 mutations predispose to early onset breast cancer in women and are associated with Li-Fraumeni syndrome. Published data on the pathological characteristics of breast cancer among women with TP53 mutations is limited...
  26. doi request reprint Sentinel lymph node dissection is technically feasible in older breast cancer patients
    Vicente Valero
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Clin Breast Cancer 10:477-82. 2010
    ..This study was undertaken to compare identification rates in patients 70 years of age and older versus those younger than 70 years in a large cohort undergoing sentinel lymph node dissection (SLND)...
  27. doi request reprint Effect of age and race on quality of life in young breast cancer survivors
    Phuong Khanh Morrow
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Electronic address
    Clin Breast Cancer 14:e21-31. 2014
    ..Given their early age at diagnosis, young breast cancer survivors (YBCSs) face issues that differ widely from their older counterparts...